HeLa cells overexpressing PON2 are resistant to hydrogen peroxide-induced oxidative stress (Ng et al. 2001), while bladder cancer cells with transient PON2 overexpression show reduced ROS generation upon tert-butyl hydroperoxide treatment (Bacchetti et al. 2017). The gene discussed is PON2; the disease is urinary bladder cancer.